Cited by 84

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages

Borrell-Pagès, Maria, Romero, July Carolina, Juan-Babot, Oriol, Badimon, Lina·2011·European Heart Journal

Abstract

Aims Atherosclerosis plaque development includes infiltration of inflammatory cells, accumulation of lipids and fibrous cap formation. Low-density lipoprotein receptor-related protein 1 (LRP1) is expressed on atherosclerotic lesions associated with macrophages and vascular smooth muscle cells. The aim of this work is to analyse the role in atherosclerosis lesion progression of another member of the LDL receptor protein family, low-density lipoprotein receptor-related protein 5 (LRP5), a co-receptor with Frizzled known to activate the Wnt signalling pathway in several cell types. Methods and results LRP5 is expressed in human vascular and innate inflammatory cells. LRP5 is transcriptionally regulated by aggregated LDL (agLDL), participating in the lipid uptake and transformation of macrophages into foam cells, a critical step in atherosclerosis progression. AgLDL-treated macrophages show up-regulated expression of β-catenin, LEF1, c-jun, cyclinD1, bone morphogenetic protein 2 (BMP2), and osteopontin (OPN), proteins and targets of the Wnt signalling pathway, whereas LRP5-silenced macrophages show a significant down-regulation of OPN and BMP2 expression. Furthermore, LRP5-deficient macrophages exhibit an impaired migration both in wound-repair and modified Boyden chambers models. Conclusion These results demonstrate the involvement of LRP5 in the innate inflammatory reaction to lipid infiltration in atherosclerosis.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr062

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Fuster, 1992, The pathogenesis of coronary artery disease and the acute coronary syndromes (1), N Engl J Med, 23, 242
  2. Hurt-Camejo, 1997, Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis, Arterioscler Thromb Vasc Biol, 17, 1011, 10.1161/01.ATV.17.6.1011 · DOI
  3. Frank, 1989, Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching, J Lipid Res, 30, 967, 10.1016/S0022-2275(20)38299-7 · DOI
  4. Williams, 2001, Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis, Curr Opin Lipidol, 12, 477, 10.1097/00041433-200110000-00002 · DOI
  5. Khoo, 1988, Enhanced macrophage uptake of low-density-lipoprotein after self-aggregation, Arteriosclerosis, 8, 348, 10.1161/01.ATV.8.4.348 · DOI
  6. Zhang, 2000, Plasmin-mediated macrophage reversal of low-density-lipoprotein aggregation, J Biol Chem, 275, 33176, 10.1074/jbc.M908714199 · DOI
  7. Kruth, 2002, Sequestration of aggregated low-density-lipoproteins by macrophages, Curr Opin Lipidol, 13, 483, 10.1097/00041433-200210000-00003 · DOI
  8. Tertov, 1992, Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation, Circ Res, 71, 218, 10.1161/01.RES.71.1.218 · DOI
  9. Llorente-Cortés, 2000, LDL-receptor-related-protein mediates uptake of aggregated LDL in HVSMC, Arterioscler Thromb Vasc Biol, 20, 1572, 10.1161/01.ATV.20.6.1572 · DOI
  10. Llorente-Cortés, 2002, Low-density-lipoprotein upregulates low-density lipoprotein-receptor-related protein expression in VSMC: possible involvement of SRBP-2-dependent mechanism, Circulation, 106, 3104, 10.1161/01.CIR.0000041434.28573.0B · DOI
  11. Llorente-Cortés, 2006, Cholesteryl esters of aggregated-LDL are internalized by selective uptake in HVSMC, Arterioscler Thromb Vasc Biol, 26, 117, 10.1161/01.ATV.0000193618.32611.8b · DOI
  12. Hiltunen, 1998, Expression of LDL-receptor, VLDL-receptor, LDL-receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL-receptor expression during lesion development, Circulation, 97, 1079, 10.1161/01.CIR.97.11.1079 · DOI
  13. Llorente-Cortés, 2004, Intracellular lipid accumulation, low-density-lipoprotein-receptor-related protein expression, and cell survival in VSMC derived from normal and atherosclerotic human coronaries, Eur J Clin Invest, 34, 182, 10.1111/j.1365-2362.2004.01316.x · DOI
  14. Llorente-Cortés, 2007, Sterol regulatory element binding proteins downregulate LRP1 expression and LRP1-mediated aggregated LDL uptake by human macrophages, Cardiovasc Res, 74, 526, 10.1016/j.cardiores.2007.02.020 · DOI
  15. Johnson, 2004, The high bone mass family—the role of Wnt/Lrp5 signaling in the regulation of bone mass, J Musculoskelet Neuronal Interact, 4, 135
  16. Howe, 1999, Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells, Cancer Res, 59, 1572
  17. Mann, 1999, Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas, Proc Natl Acad Sci USA, 96, 1603, 10.1073/pnas.96.4.1603 · DOI · Paper page
  18. Van Der Heyden, 1998, Identification of connexin 43 as a functional target for Wnt signalling, J Cell Sci, 111, 1741, 10.1242/jcs.111.12.1741 · DOI
  19. Shtutman, 1999, The cyclinD1 gene is a target of the beta-catenin/LEF-1 pathway, Proc Natl Acad Sci USA, 96, 5522, 10.1073/pnas.96.10.5522 · DOI · Paper page
  20. Müller, 2002, Regulation of epithelial cell migration and tumor formation by beta-catenin signaling, Exp Cell Res, 280, 119, 10.1006/excr.2002.5630 · DOI
  21. Dell'Accio, 2006, Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury, Arthritis Res Ther, 8, 139, 10.1186/ar2029 · DOI
  22. Sakr, 2001, The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity, J Biol Chem, 276, 37649, 10.1074/jbc.M105129200 · DOI
  23. Morita, 2004, Ceramide in lipid particles enhances heparan-sulfate proteoglycan and low-density-lipoprotein-receptor-related protein-mediated uptake by macrophages, J Biol Chem, 279, 24355, 10.1074/jbc.M402035200 · DOI
  24. Silverstein, 2009, Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36, Cleve Clin J Med, 76, S27, 10.3949/ccjm.76.s2.06 · DOI
  25. Qiu, 2010, Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical WNT signaling and C/EBP, J Biol Chem, 285, 14438, 10.1074/jbc.M109.052001 · DOI
  26. Haÿ, 2009, N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling, PLoS One, 4, e8284, 10.1371/journal.pone.0008284 · DOI
  27. Dhore, 2001, Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques, Arterioscler Thromb Vasc Biol, 21, 1998, 10.1161/hq1201.100229 · DOI
  28. Lund, 2009, The role of osteopontin in inflammatory processes, J Cell Commun Signal, 3, 311, 10.1007/s12079-009-0068-0 · DOI
  29. Boström, 1993, Bone morphogenetic protein expression in human atherosclerotic lesions, J Clin Invest, 91, 1800, 10.1172/JCI116391 · DOI
  30. de Kleijn, 2010, Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events, Arterioscler Thromb Vasc Biol, 30, 612, 10.1161/ATVBAHA.109.194944 · DOI
  31. Jiao, 2010, c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion, J Biol Chem, 285, 8218, 10.1074/jbc.M110.100792 · DOI
  32. Zhong, 2010, CyclinD1/cyclin-dependent kinase-4 interacts with filamin-A and affects the migration and invasion potential of breast cancer cells, Cancer Res, 70, 2105, 10.1158/0008-5472.CAN-08-1108 · DOI
  33. Webb, 2007, Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy, Curr Drug Targets, 8, 1249, 10.2174/138945007783220597 · DOI
  34. Choudhury, 2005, Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis, Nat Clin Pract Cardiovasc Med, 2, 309, 10.1038/ncpcardio0195 · DOI
  35. Fujino, 2003, LRP5 is essential for normal cholesterol metabolism and glucose-induced secretion, Proc Natl Acad Sci USA, 100, 229, 10.1073/pnas.0133792100 · DOI · Paper page
  36. Magoori, 2003, Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis mice lacking both LRP5 and apolipoprotein E., J Biol Chem, 278, 11331, 10.1074/jbc.M211987200 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Borrell-Pagès, M., Romero, J. C., Juan-Babot, O., & Badimon, L.
Venue
European Heart Journal
Published
2011-03-12
Volume
32
Issue
22
Pages
2841-2850
ISSN
  • 1522-9645
  • 0195-668X
Cited by
84
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review